Drug Giant Could Help Boost Biotech ETF Rally

The last time Celgene Corporation (NASDAQ:CELG) reported earnings back in April, Wall Street analysts were not too enthused with the cautious tone from management (nor the EPS and revenue guidance), which all came in below expectations.
NASDAQ:BLUE July 27, 2016 2:08pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular

From Our Partners

Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories